Cerivastatin 0.15μM R05 exp226 [The Human Chemical-Genetic Interaction Map Project]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Cerivastatin 0.15μM R05 exp226 ======
==== Mechanism of Action ====
Inhibits HMG-CoA reductase, decreases cholesterol biogenesis, upregulates LDL receptors
  * **<color #00a2e8>Class / Subclass 1:</color>** Metabolism / Metabolic Enzyme Inhibitor




==== Technical Notes ====
<accordion collapsed='true'>
<panel title='Compound References' collapsed='true'>
    * **<color #00a2e8>PubChem Name:</color>** %%Cerivastatin sodium%%
    * **<color #00a2e8>Synonyms:</color>** N/A
    * **<color #00a2e8>CAS #:</color>** 143201-11-0
    * **<color #00a2e8>PubChem CID:</color>** [[https://pubchem.ncbi.nlm.nih.gov/compound/23663992|23663992]]
    * **<color #00a2e8>IUPAC:</color>** %%sodium;(E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoate%%
    * **<color #00a2e8>INCHI Name:</color>** InChI=1S/C26H34FNO5.Na/c1-15(2)25-21(11-10-19(29)12-20(30)13-23(31)32)24(17-6-8-18(27)9-7-17)22(14-33-5)26(28-25)16(3)4;/h6-11,15-16,19-20,29-30H,12-14H2,1-5H3,(H,31,32);/q;+1/p-1/b11-10+;/t19-,20-;/m1./s1
    * **<color #00a2e8>INCHI Key:</color>** GPUADMRJQVPIAS-QCVDVZFFSA-M
    * **<color #00a2e8>Molecular Weight:</color>** 481.5
    * **<color #00a2e8>Canonical SMILES:</color>** CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)C=CC(CC(CC(=O)[O-])O)O.[Na+]
    * **<color #00a2e8>Isomeric SMILES:</color>** CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)/C=C/[C@H](C[C@H](CC(=O)[O-])O)O.[Na+]
    * **<color #00a2e8>Molecular Formula:</color>** C26H33FNNaO5
{{:chemogenomics:structures:chem-0131.svg?nolink}}
</panel>


<panel title='Compound Supplier' collapsed='true'>
    * **<color #00a2e8>Supplier Name:</color>** In house - University of Montreal - Chemistry Platform
    * **<color #00a2e8>Catalog #:</color>** N/A
    * **<color #00a2e8>Lot #:</color>** N/A
</panel>


<panel title='Compound Characterization' collapsed='true'>
    * **<color #00a2e8>HRMS (ESI-TOF) m/z:</color>** (M+Na)+ Calcd for C26H35FNO5 483.23915; found 483.2366
</panel>


<panel title='Dose Response Curve' collapsed='true'>
    * **<color #00a2e8>Platform ID:</color>** Ceriva
    * **<color #00a2e8>Min:</color>** -2.1969; **<color #00a2e8>Max:</color>** 88.6305
{{:chemogenomics:dose_response:dr_196.png?nolink&500 |}}
\\ 
\\ 
\\ 
\\ 
|< 300px 100px 200px >|
^ IC   ^ Concentration (µM) ^
| IC10  |N/A    |
| IC20  |0.0453    |
| IC30  |0.0841    |
| IC40  |0.1396    |
| IC50  |0.2224    |
| IC60  |N/A    |
| IC70  |N/A    |
| IC80  |N/A    |
| IC90  |N/A    |
\\ 
</panel>
</accordion>
==== Screen Summary ====
    * **<color #00a2e8>Round</color>**: 05
    * **<color #00a2e8>Dose</color>**: 150nM
    * **<color #00a2e8>Days of incubation</color>**: 8
    * **<color #00a2e8>Doublings</color>**: 4.5
    * **<color #00a2e8>Numbers of reads</color>**: 25325493


==== Screen Results ====


^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|57/46|<color #e85500>[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Cerivastatin_0.15uM_Round-5_exp226.txt|Scores]]</color>|<button type="primary" size="sm" modal="ScorePlot">View</button>|<button type="primary" size="sm" modal="modal_hits">View</button>|<button type="primary" size="sm" modal="modal_screen_similarity">View</button>|<button type="primary" size="sm" modal="modal_go_sensitive">View</button>|<button type="primary" size="sm" modal="modal_go_resistant">View</button>|
<modal id='ScorePlot' size='lg' title='Cerivastatin 0.15μM R05 exp226'>
{{:chemogenomics:cranks_plots:exp226.png?nolink}}
</modal>


<modal id="modal_hits" size="sm" title="Top 30 S/R Genes">
^Gene^CRANKS Score^FDR^
|[[:human_genes:S:SREBF2|SREBF2]]|-5.95|<0.01|
|[[:human_genes:S:SCAP|SCAP]]|-5.36|<0.01|
|[[:human_genes:R:RAB1B|RAB1B]]|-5.14|<0.01|
|[[:human_genes:C:C12orf49|C12orf49]]|-4.96|<0.01|
|[[:human_genes:K:KIAA1432|KIAA1432]]|-4.63|<0.01|
|[[:human_genes:U:UNC50|UNC50]]|-4.19|<0.01|
|[[:human_genes:M:MBTPS2|MBTPS2]]|-4.04|<0.01|
|[[:human_genes:A:ACAT2|ACAT2]]|-3.76|<0.01|
|[[:human_genes:S:SLC35E1|SLC35E1]]|-3.75|<0.01|
|[[:human_genes:C:COG7|COG7]]|-3.66|<0.01|
|[[:human_genes:Y:YPEL5|YPEL5]]|-3.57|<0.01|
|[[:human_genes:S:SLC10A7|SLC10A7]]|-3.47|<0.01|
|[[:human_genes:R:RAB1A|RAB1A]]|-3.46|<0.01|
|[[:human_genes:N:NADK|NADK]]|-3.23|<0.01|
|[[:human_genes:U:USO1|USO1]]|-3.19|<0.01|
|[[:human_genes:M:MBTPS1|MBTPS1]]|-3.16|<0.01|
|[[:human_genes:S:SEC31A|SEC31A]]|-3.13|<0.01|
|[[:human_genes:S:SEC63|SEC63]]|-2.98|<0.01|
|[[:human_genes:E:ENTPD4|ENTPD4]]|-2.96|<0.01|
|[[:human_genes:C:CARM1|CARM1]]|-2.90|<0.01|
|[[:human_genes:M:MCTS1|MCTS1]]|-2.90|<0.01|
|[[:human_genes:P:PITPNB|PITPNB]]|-2.87|<0.01|
|[[:human_genes:S:SLC39A9|SLC39A9]]|-2.82|<0.01|
|[[:human_genes:F:FAM122A|FAM122A]]|-2.82|<0.01|
|[[:human_genes:A:ABCG1|ABCG1]]|-2.80|<0.01|
|[[:human_genes:C:CNOT2|CNOT2]]|-2.69|<0.01|
|[[:human_genes:Z:ZNF148|ZNF148]]|-2.67|<0.01|
|[[:human_genes:G:GGPS1|GGPS1]]|-2.65|<0.01|
|[[:human_genes:R:RABGGTA|RABGGTA]]|-2.63|0.01|
|[[:human_genes:D:DPAGT1|DPAGT1]]|-2.61|0.01|
|[[:human_genes:P:PEX1|PEX1]]|2.65|<0.01|
|[[:human_genes:M:MAP2K5|MAP2K5]]|2.66|<0.01|
|[[:human_genes:H:HNRNPA0|HNRNPA0]]|2.66|<0.01|
|[[:human_genes:G:GATA3|GATA3]]|2.66|<0.01|
|[[:human_genes:B:BPTF|BPTF]]|2.71|<0.01|
|[[:human_genes:C:C7orf26|C7orf26]]|2.72|<0.01|
|[[:human_genes:P:PEX12|PEX12]]|2.73|<0.01|
|[[:human_genes:I:INTS12|INTS12]]|2.74|<0.01|
|[[:human_genes:H:HSD17B12|HSD17B12]]|2.76|<0.01|
|[[:human_genes:A:ACTR5|ACTR5]]|2.81|<0.01|
|[[:human_genes:C:CLK3|CLK3]]|2.82|<0.01|
|[[:human_genes:E:EBAG9|EBAG9]]|2.87|<0.01|
|[[:human_genes:P:POLR2G|POLR2G]]|2.91|<0.01|
|[[:human_genes:B:BRD2|BRD2]]|2.93|<0.01|
|[[:human_genes:G:GID4|GID4]]|2.99|<0.01|
|[[:human_genes:I:INSIG1|INSIG1]]|3.06|<0.01|
|[[:human_genes:P:PEX3|PEX3]]|3.18|<0.01|
|[[:human_genes:P:PEX6|PEX6]]|3.26|<0.01|
|[[:human_genes:T:TAF1|TAF1]]|3.27|<0.01|
|[[:human_genes:R:RAB7A|RAB7A]]|3.49|<0.01|
|[[:human_genes:P:PIH1D1|PIH1D1]]|3.51|<0.01|
|[[:human_genes:S:SREBF1|SREBF1]]|3.53|<0.01|
|[[:human_genes:I:INTS10|INTS10]]|3.55|<0.01|
|[[:human_genes:H:HSP90B1|HSP90B1]]|3.64|<0.01|
|[[:human_genes:A:ACSL3|ACSL3]]|3.69|<0.01|
|[[:human_genes:F:FDFT1|FDFT1]]|3.81|<0.01|
|[[:human_genes:A:ACACA|ACACA]]|4.71|<0.01|
|[[:human_genes:A:ABCD3|ABCD3]]|5.28|<0.01|
|[[:human_genes:L:LDLR|LDLR]]|5.66|<0.01|
|[[:human_genes:L:LDLRAP1|LDLRAP1]]|6.60|<0.01|
</modal>


<modal id="modal_screen_similarity" size="lg" title="Correlated Screens">
^Screen^Correlation^Plot^
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|0.287|<button type="primary" size="small" modal="1">View</button>|
|[[:results:exp67|BVD-523 15μM R02 exp67]]|0.064|<button type="primary" size="small" modal="2">View</button>|
|[[:results:exp169|BH1 1μM R04 exp169]]|0.057|<button type="primary" size="small" modal="3">View</button>|
</modal>


<modal id="1" size="lg" title="Cerivastatin 0.15μM R05 exp226  vs  Fluvastatin 2.2μM R06 exp282">
{{:chemogenomics:comparison_plots:exp226_vs_exp282.png?nolink |}}
</modal>

<modal id="2" size="lg" title="BVD-523 15μM R02 exp67  vs  Cerivastatin 0.15μM R05 exp226">
{{:chemogenomics:comparison_plots:exp226_vs_exp67.png?nolink |}}
</modal>

<modal id="3" size="lg" title="BH1 1μM R04 exp169  vs  Cerivastatin 0.15μM R05 exp226">
{{:chemogenomics:comparison_plots:exp169_vs_exp226.png?nolink |}}
</modal>



<modal id="modal_go_sensitive" size="lg" title="Top 30 sensitive GO terms">
^GO Term^Fold Change^Genes^
|positive regulation of sterol biosynthetic process|263.02|SREBF2,SCAP,ABCG1|
|positive regulation of cholesterol metabolic process|153.43|SREBF2,SCAP,ABCG1|
|regulation of sterol biosynthetic process|136.38|SCAP,MBTPS2,MBTPS1,ABCG1|
|regulation of cholesterol biosynthetic process|136.38|SREBF2,MBTPS2,MBTPS1,ABCG1|
|COPII-coated vesicle cargo loading|131.51|SCAP,RAB1A,SEC31A|
|positive regulation of steroid biosynthetic process|92.06|SREBF2,SCAP,ABCG1|
|regulation of cholesterol metabolic process|90.25|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|ER-nucleus signaling pathway|87.67|SREBF2,SCAP,MBTPS2,MBTPS1|
|positive regulation of alcohol biosynthetic process|76.71|SREBF2,SCAP,ABCG1|
|regulation of alcohol biosynthetic process|63.93|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|regulation of steroid biosynthetic process|42.03|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|ER to Golgi transport vesicle membrane|41.61|SREBF2,SCAP,USO1,SEC31A|
|regulation of steroid metabolic process|32.30|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|cholesterol metabolic process|26.68|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|endoplasmic reticulum to Golgi vesicle-mediated transport|24.75|SCAP,RAB1B,RAB1A,USO1,SEC31A|
|secondary alcohol metabolic process|24.55|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|sterol metabolic process|23.97|SREBF2,SCAP,MBTPS2,MBTPS1,ABCG1|
|Golgi vesicle transport|17.92|SCAP,RAB1B,COG7,SLC10A7,RAB1A,USO1,SEC31A,PITPNB|
|Golgi membrane|13.12|SREBF2,SCAP,RAB1B,RIC1,UNC50,MBTPS2,COG7,SLC10A7,RAB1A,USO1,MBTPS1,ENTPD4,PITPNB,ABCG1|
</modal>
<modal id="modal_go_resistant" size="lg" title="Top 30 resistant GO terms">
^GO Term^Fold Change^Genes^
|protein import into peroxisome matrix, receptor recycling|276.17|PEX6,PEX12,PEX1|
|protein import into peroxisome matrix|157.81|PEX6,PEX12,PEX1,PEX26|
|peroxisomal membrane transport|157.81|ABCD3,PEX6,PEX3,PEX12,PEX1,PEX26|
|protein targeting to peroxisome|145.35|PEX6,PEX3,PEX12,PEX1,PEX26|
|peroxisomal transport|144.09|ABCD3,PEX6,PEX3,PEX12,PEX1,PEX26|
|protein localization to peroxisome|116.28|PEX6,PEX3,PEX12,PEX26|
|establishment of protein localization to peroxisome|116.28|PEX6,PEX12,PEX1,PEX26|
|peroxisome organization|100.42|ABCD3,PEX6,PEX3,PEX12,PEX1,PEX26|
|microbody membrane|60.41|ABCD3,ACSL3,PEX6,PEX3,PEX12,PEX1,PEX26|
|peroxisomal membrane|60.41|ABCD3,ACSL3,PEX6,PEX3,PEX12,PEX1,PEX26|
|protein transmembrane import into intracellular organelle|59.71|PEX6,PEX12,PEX1,PEX26|
|intracellular protein transmembrane transport|41.69|PEX6,PEX12,PEX1,PEX26|
|microbody|27.04|ABCD3,ACSL3,PEX6,PEX3,PEX12,PEX1,PEX26|
|peroxisome|27.04|ABCD3,ACSL3,PEX6,PEX3,PEX12,PEX1,PEX26|
|steroid biosynthetic process|24.88|ABCD3,FDFT1,SREBF1,INSIG1,HSD17B12|
|cholesterol metabolic process|24.01|LDLRAP1,LDLR,FDFT1,SREBF1,INSIG1|
|secondary alcohol metabolic process|22.09|LDLRAP1,LDLR,FDFT1,SREBF1,INSIG1|
|sterol metabolic process|21.58|LDLRAP1,LDLR,FDFT1,SREBF1,INSIG1|
|steroid metabolic process|15.34|LDLRAP1,LDLR,ABCD3,FDFT1,SREBF1,INSIG1,HSD17B12|
</modal>